Af­ter biotech im­plo­sions, ex-Mil­len­ni­um chief Deb­o­rah Dun­sire is tak­ing the helm at Lund­beck

Deb­o­rah Dun­sire is mov­ing to Den­mark.

Af­ter bounc­ing around the high-risk biotech world in Boston/Cam­bridge for the past few years, ex-Mil­len­ni­um chief Dun­sire is now tak­ing the top seat at Den­mark’s Lund­beck, left va­cant af­ter Kåre Schultz jumped to Te­va.

A high-pro­file ex­ec in the US, Dun­sire left Mil­len­ni­um as Take­da ab­sorbed and re­struc­tured the com­pa­ny, mak­ing it a cen­tral part of their US hub. She lat­er took the helm at Fo­rum Phar­ma­ceu­ti­cals, leav­ing not long af­ter the com­pa­ny was hit by a clin­i­cal hold on Alzheimer’s and a failed clin­i­cal pro­gram in schiz­o­phre­nia. 

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.